副研究员，硕士研究生导师，医院优秀科研人才。
博士毕业于中山大学肿瘤防治中心华南肿瘤学国家重点实验室。主要研究方向为皮肤创伤愈合和纤维化的分子机制。以第一作者或通讯作者发表SCI论文8篇，其中影响因子大于10的论文3篇，中科院小类分区1区论文5篇，包括Nature Communications、Cancer Research、British Journal of Dermatology、Journal of Investigative Dermatology（2篇）等。主要学术业绩：在单细胞水平上，解析了皮肤纤维化疾病瘢痕疙瘩中成纤维细胞的异质性，发现mesenchymal成纤维细胞亚群在瘢痕疙瘩中相对于正常瘢痕显著增多（Nature Communications，2021）。解析了瘢痕疙瘩易感位点rs1348270通过调控lncRNA DEIK表达影响瘢痕疙瘩发生发展的作用和分子机制（British Journal of Dermatology，2023）。在原代培养成纤维细胞和临床组织中，以细胞生物学、分子生物学和生物化学等实验方法和技术，探索了TRAF4通过结合去泛素酶USP10抑制p53表达促进瘢痕疙瘩成纤维细胞过度增殖的功能和机理（Journal of Investigative Dermatology，2019）。主持国家自然科学基金、广东省自然科学基金和南方医科大学优青培育项目在内的多项科研课题。担任Journal of Investigative Dermatology，Experimental Dermatology等期刊审稿专家、中华医学会皮肤
性病分会瘢痕疙瘩与增生性瘢痕疾病研究中心成员、广东省精准医学应用学会单细胞科技分会委员等职务。
代表性论文
1. Deng CC#, Zhang LX#, Xu XY#, Zhu DH, Cheng Q, Ma SF, Rong ZL*, Yang B*. Risk SNP-mediated enhancer-promoter interaction drives keloid through lncRNA DEIK. British Journal of Dermatology, 2023, 23;188(1):84-93. (IF=11.113，小类1区)
2. Gu JJ#, Deng CC#, Feng QL, Liu J, Zhu DH, Cheng Q, Rong Z*, Yang B*. Relief of Extracellular Matrix Deposition Repression by Downregulation of IRF1-Mediated TWEAK/Fn14 Signaling in Keloids. Journal of Investigative Dermatology. 2023 Jan 28:S0022-202X(23)00026-X. (IF=7.59，小类1区)
3. Feng QL#, Gu JJ#, Chen JY, Zheng WY, Pan HH, Xu XY, Deng CC*, Yang B*. TSP1 promotes fibroblast proliferation and extracellular matrix deposition via the IL6/JAK2/STAT3 signalling pathway in keloids. Experimental Dermatology, 2022, 31(10):1533-1542. (IF=4.511，小类3区)
4. Deng CC#, Hu YF#, Zhu DH#, Cheng Q, Gu JJ, Feng QL, Zhang LX, Xu YP, Wang D, Rong ZL*, Yang B*. Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases. Nature Communications, 2021, 12(1):3709. (IF=17.694，小类1区)
5. Deng CC#, Zhu DH#, Chen YJ, Huang TY, Peng Y, Liu SY, Lu P, Xue YH, Xu YP, Yang B*, Rong ZL*. TRAF4 promotes fibroblast proliferation in keloids by destabilizing p53 via interacting with the deubiquitinase USP10. Journal of Investigative Dermatology, 2019, 139(9): 1925-1935. (IF=7.59，小类1区)
6. Deng CC#, Lin YX#, Qi XK#, He GP, Zhang YC, Zhang HJ, Xu M, Feng QS, Bei JX, Zeng YX*, Feng L*. TNFRSF19 inhibits TGFβ signaling through interaction with TGFβ receptor type I to promote tumorigenesis. Cancer Research, 2018, 78(13): 3469-3483. (IF=13.312，小类1区)
7. Deng CC#, Xu M#, Li J#, Luo XL, Zhu YJ, Jiang R, Zhang MX, Lei JJ, Lian YF, Zou X, You R,Chen LZ, Feng QS, Bei JX, Chen MY*, Zeng YX*. Unconjugated Bilirubin Is a Novel Prognostic Biomarker for Nasopharyngeal Carcinoma and Inhibits Its Metastasis via Antioxidation Activity. Cancer Prevention Research, 2016, 9(2): 180-188. (IF=3.296，小类3区)
8. Deng CC, Liang Y, Wu MS, Feng FT, Hu WR, Chen LZ, Feng QS, Bei JX, Zeng YX*. Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma. The international journal of biochemistry & cell biology, 2013, 45(9): 1997-2006. (IF=5.652，小类3区)